Sitryx is Biotechnology in United Kingdom that focus on technology leverages business. Founded in 2016. They cover business area such as developer, small molecule drug, disease-modify therapeutic, immuno-oncology and immuno-inflammation, differentiate chemistry approach, proteolysis target chimaera, (PROTACS, topical formulation, a portfolio, project, oncology and immuno-inflammatory indication, healthcare worker, immunometabolic therapy, cancer.
2016
( 8 years old in 2024 )
Technology Leverages
-
101 Bellhouse Building, Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA
England, United Kingdom
Private
developersmall molecule drugdisease-modify therapeuticimmuno-oncology and immuno-inflammationdifferentiate chemistry approachproteolysis target chimaera(PROTACStopical formulationa portfolioprojectoncology and immuno-inflammatory indicationhealthcare workerimmunometabolic therapycancer
* We use standard office opening hours in near Sitryx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sitryx is Biotechnology business from United Kingdom that founded in 2016 (8 years old in 2024), Sitryx business is focusing on Technology Leverages.
Sitryx headquarter office and corporate office address is located in 101 Bellhouse Building, Magdalen Centre The Oxford Science Park Oxford OX4 4GA England, United Kingdom.
Sitryx was founded in United Kingdom.
In 2024, Sitryx is currently focus on technology leverages sector.
Above is snippet of Google Trends for "technology leverages" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sitryx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
